Related references
Note: Only part of the references are listed.Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation
Maokai Gong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Paraoxonase: A multifaceted biomolecule
Binita Goswami et al.
CLINICA CHIMICA ACTA (2009)
The paraoxonases: role in human diseases and methodological difficulties in measurement
Jordi Camps et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Anti-inflammatory activity of naringin and the biosynthesised naringenin by naringinase immobilized in microstructured materials in a model of DSS-induced colitis in mice
Maria Ines Amaro et al.
FOOD RESEARCH INTERNATIONAL (2009)
Paraoxonase 1 (PON1) status and substrate hydrolysis
Rebecca J. Richter et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model
Bilal Ustundag et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon?
Silvina B. Lotito et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences
M Aviram et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
The paraoxonase gene family and atherosclerosis
CJ Ng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes
M Harel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Review of the flavonoids quercetin, hesperetin naringenin. Dietary sources, bioactivities, and epidemiology
I Erlund
NUTRITION RESEARCH (2004)
The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia
BV Kural et al.
CORONARY ARTERY DISEASE (2004)
Pharmacogenetics of paraoxonases: a brief review
DI Draganov et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism
C Gouédard et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Enhancing effect of lipids and emulsifiers on the accumulation of quercetin metabolites in blood plasma after the short-term ingestion of onion by rats
K Azuma et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2003)
Structure-activity relationship on human serum paraoxonase (PON1) using substrate analogues and inhibitors
RS Bargota et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy
J Vaya et al.
PHYTOCHEMISTRY (2003)
Paraoxonase and coronary heart disease
MI Mackness et al.
ATHEROSCLEROSIS SUPPLEMENTS (2002)
The biochemistry and medical significance of the flavonoids
BH Havsteen
PHARMACOLOGY & THERAPEUTICS (2002)
Supplementation of naringenin and its synthetic derivative alters antioxidant enzyme activities of erythrocyte and liver in high cholesterol-fed rats
MK Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Dietary determinants of serum paraoxonase activity in healthy humans
P Kleemola et al.
ATHEROSCLEROSIS (2002)
Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits
SM Jeon et al.
CLINICA CHIMICA ACTA (2002)
Share Paper
